AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Science Group plc (the ‘Company’) together with its subsidiaries (‘Science Group’ or the ‘Group’) reports its audited results for the year ended 31 December 2019.
- Organic business performance in line with upgraded expectations.
- Acquisition of Frontier Smart Technologies completed, funded primarily from existing cash resources.
- Frontier restructuring and integration programme effectively completed. Costs recognised in 2019.
- Group retains a strong balance sheet with significant freehold property assets.
Science Group plc
Martyn Ratcliffe, Chairman
Rebecca Archer, Finance Director
Tel +44 (0) 1223 875200
Nominated Adviser: Dominic Morley, Alina Vaskina
Corporate Broking: Erik Anderson
Tel: +44 (0) 20 7886 2500
MHP Communications (PR Advisor to Science Group)
Reg Hoare, Pete Lambie
Tel: +44 (0) 20 3128 8100
* Alternative performance measures are provided in order to enhance the shareholders’ ability to evaluate and analyse the underlying financial performance of the Group. Refer to Note 1 for detail and explanation of the measures used.
Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014).
Science Group plc together with its subsidiaries is an international, science & technology services and product development organisation, supported by a strong balance sheet including significant freehold property assets. In 2019, the Group delivered a consistent operating performance from its organic business activities and completed a major acquisition followed by an accelerated restructuring and integration programme. As a result, the progress of Science Group has continued despite the background of macroeconomic and political uncertainty during 2019.
The strategy of enhancing the organic development of the Group through acquisitions has created a financially and operationally resilient organisation. The acquisition of Frontier Smart Technologies Group Limited (‘Frontier’) was again funded primarily from the Group’s existing cash resources, minimising shareholder dilution. This strategy has delivered a substantial increase in scale, profit and the asset base of the Group, with offices in UK, Europe, North America and Asia, serving a range of vertical markets including medical, consumer, food & beverage and industrial sectors.
Organic business performance in 2019 was positive. The Group’s statutory results for the year are significantly influenced by the Frontier acquisition and the associated intensive restructuring undertaken to position the Group to realise the benefit in 2020 and beyond. As explained within this report, the accounting treatment associated with the acquisition is complex and, in order to provide transparency to shareholders, the Group results are summarised in the table below.
For the year ended 31 December 2019, Group revenue was £57.2 million (2018: £48.7 million) of which organic revenue was £49.7 million (2018: £48.3 million excluding exited operations). Adjusted operating profit (‘AOP’) for the organic business for the year ended 31 December 2019 was in line with the Board’s expectations at the time of the October trading update, despite the negative impact of foreign currency movements during the last few months of the year, a period of considerable volatility for Sterling. The Group result comprised a profit contribution of £8.0 million (2018: £7.6 million excluding exited operations) from organic business activities and a loss of £1.3 million from the Frontier operations, as anticipated. (Adjusted operating profit and other Alternative Performance Measures used in this report are defined in the Finance Director’s Report. The Group exited operations in Central Europe in H1 2018 and the continuing measure provides comparability.)
In line with the Group’s established model, acquisition restructuring and integration have been expedited and associated costs recognised at the earliest opportunity. Costs related to the Frontier acquisition including professional fees; share revaluation; property lease provisions; and the integration/restructuring process totalled £4.1 million. Amortisation of acquisition related intangibles and share based payment charge totalled £3.5 million (2018: £2.8 million) and as a result, in line with the Board’s expectations, the Group reported an operating loss of £0.2 million for the year (2018: profit of £5.3 million).
The Group maintains a strong balance sheet, even after the Frontier acquisition, with significant cash resources, low debt and two substantial freehold properties hosting the Group’s main UK laboratories and offices (see below).
Reflecting the deployment of cash to acquire Frontier, at 31 December 2019, gross cash was £13.9 million (2018: £21.5 million) and net debt was £2.3 million (2018: net funds of £8.8 million). The Group’s bank debt at 31 December 2019 was £16.2 million (2018: £12.7 million). The Group's bank debt is tied to interest rate swaps to produce a net fixed rate (effectively 3.6%) to 2026 and is secured on the Group's freehold property assets. Subject to net debt not exceeding £10 million, the bank debt is not subject to operating covenants.
During the year, the Company sold some treasury shares in association with the Frontier acquisition. As a result, at 31 December 2019, shares in issue (excluding treasury shares held of 0.4m) were 41.7 million (2018: 40.0 million). Apart from the treasury shares, the acquisition of Frontier was undertaken using the Group’s existing resources. This is consistent with the Board’s prior practice, which has delivered substantial growth in revenue and profit over the past 9 years without shareholder dilution. (Issued share capital, excluding treasury shares, at 31 December 2010 was 41.7 million, the same as at 31 December 2019.)
In recent years, the Group has progressively increased the dividend paid to shareholders ahead of the rate of inflation. Following the cash deployed in the Frontier acquisition, the Board has decided to recommend that this year the dividend is held at 4.6 pence per share. Subject to shareholder approval at the Annual General Meeting (‘AGM’), the dividend will be payable on 12 June 2020 to shareholders on the register at the close of business on 22 May 2020.
Services Operating Business Overview
For the year ended 31 December 2019, revenue from the Group’s services operating business (which excludes Frontier and property income) increased to £48.7 million (2018: £47.2 million, excluding exited operations). Adjusted operating profit generated from the services operating business was £8.2 million (2018: £7.6 million), in line with the trading update in October, despite the foreign exchange impact within the fourth quarter related to Brexit uncertainty. This profitability measure includes property rental costs charged to the services operating business at market rates on an arms-length basis. As a result, while there are operational and liability mitigation benefits from the Group’s freehold property, the financial performance of the services operating business is not enhanced by these assets.
The Group provides product development consulting services to the medical, consumer, food & beverage and industrial markets helping clients develop innovative products and technologies. Science Group services are differentiated by their combination of deep scientific understanding, engineering excellence and sector domain knowledge.
Revenues for the Product Development business increased to £23.2 million (2018: £22.0 million). The Commercial (consumer, food & beverage and industrial sectors) business delivered very strong results compared to the prior year. The Medical business, characterised by large projects with a greater customer concentration, was impacted in H1 2019 as a result of some large projects completing at the end of 2018, but recovered well in the second half of the year. The largest Product Development client accounted for £3.1 million of revenue in 2019.
The acquisition of Frontier enhances the Product Development business’ Internet of Things (‘IoT’) proposition, particularly in the Commercial sectors. Prior to the Frontier acquisition, IoT has been a growth area as companies seek to evolve their business models in line with this digital market trend. However, one of the less understood but critical aspects of deploying IoT strategies is the requirement for ongoing support infrastructure to enable, for example, the updating of firmware; system control; data analysis; and maintenance monitoring. The Nuvola infrastructure, originally established to support Frontier’s smart radio (‘SmartRadio’) and smart audio models which now has an installed base of several million field-deployed units, brings a new capability to the Group’s strategy.
The Group’s Advisory business provides clients a combination of sector understanding and science/technology expertise. These consulting services help clients innovate, typically looking at market developments and opportunities in the 3-10 year horizon. The client base is mainly large, blue-chip organisations, but project-size is typically smaller than product development projects. The largest Advisory client accounted for £1.2 million of revenue in 2019.
The Advisory business had a good performance in 2019 with revenue increasing to £8.2 million (2018: £7.6 million). The Consumer and Food & Beverage sectors performed strongly, benefitting from the Group’s wider capabilities in Product Development and Regulatory services. The Industrial (including Energy) sector performed satisfactorily.
The Regulatory businesses provide science-based regulatory consulting services to clients in the food & beverage, agritech, consumer and chemicals market sectors. The Group delivers services to clients predominantly in Europe and North America, but provides international coverage across wider geographical territories, particularly in food & beverage where services cover over 100 countries, a key differentiating factor in this global market.
The revenues from the Group’s Regulatory businesses slightly declined to £16.8 million (2018: £17.3 million from continuing operations). Performance was strong in food & beverage, reflecting the Group’s market leadership position and scalable services model. In the US regulatory business, the market was impacted significantly in the first part of the year by the federal government shutdown, recovering in the second half with growth in the federal and state renewals business which provides repeat revenue from the established client base. In Europe, the prior year benefited from a regulatory deadline relating to the REACH programme and the revenue in 2019 therefore declined slightly. The largest Regulatory client accounted for £0.5m of revenue in the year.
Science Group completed the acquisition of Frontier in October. Due to the progressive increase of the Science Group shareholding between May and October, the accounting treatment of the 2019 results is complex. In brief, prior to 11 July 2019, the shareholding was deemed to be an investment. Thereafter, Frontier was treated as an associate until 23 August 2019, at which point Science Group obtained control and the results were consolidated (with the proportion relating to the other Frontier shareholders being separately attributed). On 11 October 2019, completion of the statutory merger resulted in Science Group obtaining 100% ownership of Frontier.
The accounting treatment is further complicated by the variation in price paid per share during the course of the acquisition. On 23 August, the Group’s weighted average cost per Frontier share for shares acquired prior to that date, through on-market purchases and the formal offer (‘Offer’), was 30.6 pence, at which time Science Group owned 19.4 million shares in Frontier. The price per share for the subsequent statutory merger was 25 pence and as a result a paper accounting loss of 5.6 pence per share was incurred on the Group’s holding, equivalent to £1.1 million, although the Board’s action produced a cash saving to Science Group of approximately £2.7 million compared to the original Offer price of 35 pence per Frontier share. This unusual circumstance, which was significantly beneficial to Science Group, was only possible due to Frontier not being subject to the UK Code on Takeovers and Mergers and the Frontier Board rejecting the original Science Group Offer.
At an adjusted operating level, the underlying loss reported by Frontier was £0.8 million. In addition, acquisition accounting treatment of work-in-progress and finished goods in accordance with IFRS 3, Business Combinations, results in an adjustment of £0.5 million reported as an operating loss. Professional fees; share revaluation; property lease provisions; and the costs arising from integration/restructuring activities totalled £4.1 million.
In terms of the balance sheet on 23 August, when consolidation commenced, goodwill of £2.8 million ($3.5 million) and acquisition related intangible assets of £8.8 million ($10.7 million) were recognised. Subsequently, due to the fluctuation in exchange rates and amortisation of acquisition related intangible assets, at 31 December 2019 these balances were £2.6 million and £7.6 million respectively. Frontier also has significant unrecognised tax losses, in the order of £24 million.
Frontier Integration and Strategy
Since completion in October, a very intensive restructuring and integration programme has been executed by the new Frontier management team. Excellent progress has been made including:
- The Romanian operations have been closed and the legal entity is anticipated to be terminated in 2020;
- The Frontier London office has been closed and staff relocated to the Science Group London office;
- The Cambridge (Sawston) office has been closed and staff relocated to Science Group’s freehold facility in Harston, Cambridge, with onerous lease costs being recognised in 2019;
- In Hong Kong the office space has been reduced by approximately half with the associated onerous costs being recognised in 2019;
- A substantial reduction in the cost base has resulted in headcount reducing from 110 in October 2019 to 67 in February 2020; and
- A reduction in the number of module variants, including end-of-life programmes for unprofitable product lines.
The market for Frontier products is relatively stable with upticks in demand associated with country transitions to digital broadcasting. Frontier holds a majority share in its core digital radio (DAB/DAB+) market and demand for Frontier products is therefore fundamentally linked to the scale and dynamics of the market. Frontier has historically been over-optimistic in its forecasting and failed to manage distribution/retail channel inventory, a particular issue in late 2018 which resulted in incentives to customers towards the end of the year having a material impact on demand in 2019. This not only resulted in forecast downgrades in Frontier but such short-term incentives to customers exacerbate price/margin pressure and revenue volatility. The Frontier strategy in future will be to allow revenue to move in line with market developments to produce a more sustainable, and profitable, operating model.
The substantial reduction in the cost base resulting from the accelerated integration/restructuring programme, should enable Frontier performance to recover in 2020. However, the impact of the coronavirus (COVID-19) outbreak is uncertain, a global challenge particularly affecting production facilities in China where Frontier and Frontier customers manufacture their products. The Frontier manufacturing facility was temporarily closed but has now been partially reopened following approval from the local authority. The situation remains under close review.
Frontier revenue and material costs are transacted in US dollars, as is common practice in consumer electronics manufactured in China since most materials are priced in that currency. As a consequence, the Frontier business is exposed to exchange rate fluctuations between Sterling and US dollars.
Frontier Product Strategy
The Frontier business comprises:
DAB Radio: Frontier is the market leader in design and manufacture of chips and modules which are used in DAB radios. The skills involved in designing, developing and manufacturing these products include embedded software engineering, RF and digital hardware development and high-volume/low cost manufacturing. This product category contributes the majority of Frontier revenue.
The market of approximately 5 million chips/modules is concentrated in geographies such as Germany and the UK which have been major adopters of the DAB digital broadcast technology. The underlying, broadly flat market volume is enhanced when major geographies accelerate their national digital strategies or implement digital switchover.
SmartRadio: Frontier also designs and manufactures modules which contain internet radio technology in addition to DAB chips. The resulting products feature in an emerging category increasingly referred to as ‘SmartRadio’. These products enable consumers to listen to broadcast radio through DAB and/or a wide range of global internet radio stations in addition to music streaming services such as Spotify. The category aims to combine the simplicity of radio together with the scope of the internet, without the privacy concerns sometimes associated with the smart speaker category.
In terms of market volume, SmartRadio currently accounts for around 15% of Frontier shipments. Frontier SmartRadios are connected to the Group’s cloud platform (‘Nuvola’) which enables certain internet functionality and delivers firmware updates when required.
Smart Audio: In recent years, Frontier invested heavily in developing modules that enable voice-activated smart speakers and other audio devices. This product-line absorbed very substantial funds resulting in the lack of profitability of Frontier. While the product category contributes some valuable technology and capability in voice activation of the major ecosystems and remains part of the product portfolio, as a stand-alone product category the importance has now been de-emphasised. A provision against excess inventory was taken in 2019.
IoT: As part of Frontier’s smart radio and smart audio strategy, Frontier developed the cloud architecture, Nuvola, which enables certain functionality and firmware updates of internet-connected products in the field. This architecture has been technically well-conceived and currently supports an installed base of several million devices, of which around 1.5 million were actively connecting to Nuvola in January 2020. This architecture will continue to support Frontier products and, as explained above, will potentially provide an enabler for the Group’s wider Product Development and IoT strategies.
The last formal valuation of the Group’s freehold properties, Harston Mill, near Cambridge, and Great Burgh, near Epsom, was undertaken in March 2018. This report indicated that the aggregate ‘vacant possession’ valuation was estimated at £22.6 million and, based on market rents and property yields at that time, the aggregate sale & leaseback valuation was estimated at £33.9 million. The properties are held on the balance sheet at an aggregate value of £21.4 million (2018: £21.6 million) on the historical cost-based valuation model.
Following the 2018 strategic review, the freehold properties are managed outside of the operating business activities and the operations are charged rent and service charges on an arms-length basis. For the year ended 31 December 2019, the property business generated a total revenue of £3.9 million. This comprised £1.0 million (2018: £1.1 million) from third party tenants and £2.9 million (2018: £2.9 million) from intra-Group rental charges. On a stand-alone basis, the Group’s freehold property delivered a £1.5 million (2018: £1.6 million) adjusted operating profit, although at Group level, the intra-Group trading is eliminated on consolidation.
The vacant space in the Mill building on the Harston Mill site has been used to accommodate Frontier. During the year, one larger tenant went into insolvency and currently there is 6,000 square feet of lettable space at Harston Mill. Additional tenant turnover is anticipated in the year ahead and marketing of potential free space has been initiated.
The Board previously concluded that the Harston Mill property should be moved out of Sagentia into a separate company and this was due to be actioned early in 2020, with a corresponding tax cash outflow of approximately £2 million. The preparatory work has been completed. However, following the Frontier acquisition and the deployment of cash resources into expanding the Group’s business operations, the Board has decided to defer the Harston Mill transfer and to review later in the year. There are no material operating consequences of this deferral.
There are several external factors which may influence the Group in the year ahead.
Brexit is the highest profile political change but it remains unclear what the net effect on the Group’s services operations will be, since some capabilities may be in greater demand while R&D tax credit arrangements in EU countries may in some cases make UK consultancy services less attractive. With regard to the Frontier product business, supply is provided directly from China/Hong Kong and it is not anticipated that Brexit will have any material effect on this division. In addition to Brexit, the US Presidential election could influence Science Group’s services operations later in the year since a high proportion of this revenue is derived from North America. The Board monitors developments and awaits greater certainty before reviewing the Group’s strategy, if appropriate.
The Covid-19 virus has to date only had a minor effect and this has been in relation to the Frontier manufacturing in China. However, while the timing of the outbreak around the Lunar New Year was unfortunate, this time of year was planned to be a quieter business period due to the holiday. As a result, to date there has been only limited financial impact and the Frontier manufacturing operations have now partially reopened in accordance with local procedures. In summary, at present it is considered that any material effect on Science Group is likely to derive from the indirect consequences on the global economy (R&D investment, business travel, etc). The Board are closely monitoring the situation.
However, in regard to factors beyond the Board’s control, the greatest financial impact is likely to derive from movements in currency exchange rates with the Group benefitting from a strong US dollar and weaker Sterling. Currency rates may be directly or indirectly related to the above and/or other external factors.
The major corporate activity during 2019 was the Frontier acquisition. Not only was this the largest acquisition in the Group’s history, but it was also a complex bid for an AIM-listed, Cayman-domiciled entity, which was actively resisted by the Frontier Board. The transaction included market purchases; a formal offer; an equity investment; and finally a cross-border statutory merger, subject to English and Cayman law. The UK Code on Takeovers and Mergers did not apply.
With Frontier having operations in Cambridge, London, Romania, Hong Kong and China, the integration has been intense particularly since the operational restructuring has been effectively completed in just a few months. Finalising the corporate administrative procedures and implementing the new strategy is ongoing.
Corporate costs for the Group for the year increased to £1.7 million (2018: £1.6 million).
The financial performance of the Group’s organic operations in 2019 was in line with expectations. The Board anticipate continued progress in the year ahead and the new year has started satisfactorily.
Despite only completing the acquisition in October, the restructuring and integration of Frontier, has made very good progress, resulting in a substantial reduction in the cost base and a clear future strategy for this business. While the impact of Covid-19 cannot be fully evaluated, the Board is confident that the operational, financial and commercial transformation that has been undertaken in the last few months will render the business more resilient to external factors.
The Group retains a strong balance sheet with significant cash resources; low net debt (without any operating covenants at the current level); and substantial freehold property assets. This foundation, together with the Group’s portfolio of complementary business operations, diversified across geography and industry sectors, provides stability and opportunity in an unpredictable world.
Finance Director’s Report
Overview of results
In the year ended 31 December 2019, the Group generated revenue of £57.2 million (2018: £48.7 million) benefitting from the inclusion of 4 months trading of Frontier following the acquisition during 2019. Revenue from the services and product operating businesses, that is revenue derived from consultancy services, materials recharged on these projects and product revenue, increased to £56.2 million (2018: £47.6 million). Revenue generated by freehold properties, comprising property and associated services income derived from space let to third parties in the Harston Mill facility, was £1.0 million (2018: £1.1 million).
Adjusted operating profit for the Group of £6.7 million (2018: £7.7 million) includes an adjusted operating loss of £1.3 million for Frontier within which an acquisition accounting loss of £0.5 million arose due to the revaluation of acquired inventory. The Group statutory operating loss of £0.2 million (2018: profit of £5.3 million) includes the costs resulting from the restructuring of Frontier and the one-off costs and accounting adjustments arising from the acquisition as set out in the Chairman’s Statement. The statutory loss before tax was £1.6 million (2018: profit before tax of £4.9 million) and statutory loss after tax was £1.8 million (2018: profit after tax of £4.3 million).
(Adjusted operating profit is an alternative profit measure that is calculated as operating profit excluding amortisation of acquisition related intangible assets, impairment of investments, acquisition integration costs, share based payment charges and other specified items that meet the criteria to be adjusted. Refer to the notes to the financial statements for further information on this and other alternative performance measures).
The Frontier transaction started in early May 2019 when the initial on-market purchases of shares were made. On 11 July 2019, the Group ownership reached 35.6% and the Group commenced equity accounting for the investment. The Group continued to acquire shares on the market and made an offer for Frontier at 35 pence per share resulting in ownership of 47.5% on 19 July 2019. On 23 August 2019, through an issue of 4 million shares by Frontier, Science Group increased its ownership to 52.2% gaining control of Frontier and the consolidation of results commenced. Additional shares were acquired on the market taking the ownership to 72.3% on 6 September 2019 with the remaining Frontier shares being acquired on 11 October 2019 by way of a statutory merger. The statutory merger was effected by SG Bidco Limited (a 100% owned subsidiary of Science Group plc) merging with Frontier Smart Technologies Group Limited, the parent company of the Frontier Group, through which Science Group obtained full ownership of the Frontier business. Refer to Note 16 for further information on the acquisition process and accounting of Frontier.
Included within the Frontier adjusted operating loss for the post acquisition period is a fair value adjustment related to the acquisition accounting of inventory that increased the Frontier loss by £0.5 million. All assets and liabilities are recorded at fair value at the date of acquisition and the valuation of inventory is adjusted to take into account the work done up until this date. Therefore, work in progress and manufactured finished goods held are not valued at cost and instead the fair value is measured by taking into account the stage of development in the production cycle of the item, with the fair value being the estimated selling price less certain costs and a margin thereon. This methodology, as required under IFRS 3, Business Combinations, has resulted in an accounting adjustment to the value of acquired inventory of £0.7 million and has reduced the adjusted operating profit in 2019 by £0.5 million with the balance reducing adjusted operating profit in 2020.
The acquisition and restructuring activities have resulted in significant one-off costs including: professional fees and integration costs of £2.5 million; a provision for onerous costs relating to property leases (including an impairment of the leased right of use asset) of £1.1 million; and a loss on remeasurement of the equity investment in Frontier of £0.5 million. The capitalised acquisition related intangible assets in respect of Frontier has resulted in the associated amortisation increasing to £2.3 million (2018: £2.0 million) and the share based payment charge has increased to £1.2 million (2018: £0.8 million) due to the full year effect of the share options granted under the Enhanced Executive Incentive scheme and the increase in PSP share options granted resulting from the growth of the Group.
A significant proportion of the Group’s revenue is denominated in US Dollars and Euros and changes in exchange rates can have a significant influence on the Group’s financial performance. In 2019, £28.7 million of the Group operating business revenue was denominated in US Dollars (2018: £16.6 million), including all of Frontier revenue, and £3.6 million of the Group operating business revenue was denominated in Euros (2018: £5.7 million). The Group continues to monitor the volatility of exchange rates and to date has decided not to utilise foreign exchange hedging instruments.
IFRS 16 Leases
The Group adopted IFRS 16 Leases from 1 January 2019 using the modified retrospective approach, under which the cumulative effect of initial application is recognised in retained earnings at 1 January 2019. This applies to property leases held by the Group companies. The effect was to recognise a Right of Use asset and a Lease liability of £2.8 million at 1 January 2019. As a result, in the Consolidated Income Statement for the year ended 31 December 2019, adjusted operating profit increased by a net of £12,000 and interest cost increased by £95,000.
The tax charge for the year was £0.2 million (2018: £0.6 million). The underlying tax charge on the profits generated by the organic operating business has been partially offset against the tax income arising on losses generated by Frontier from when it was 100% owned in the Group and a Research and Development tax credit of £0.4 million (2018: £0.4 million). A significant proportion of the one-off costs resulting from the acquisition and restructuring activities are not anticipated to be tax deductible.
At 31 December 2019, Science Group had £34.7 million (2018: £10.8 million) of tax losses of which £0.2 million (2018: £0.4 million) relate to trading losses which have been recognised as a deferred tax asset and are anticipated to be used to offset future trading profits. Tax losses of £24.0 million (2018: £nil) relate to the acquired Frontier companies of which £22.4 million (2018: £nil) are held by the trading company of Frontier (Frontier Smart Technologies Limited) and would be able to be offset against future profits generated by this company but due to the uncertainty in the timing of utilisation of these losses, they have not been recognised as a deferred tax asset. The remaining tax losses of £10.5 million (2018: £10.4 million) have not been recognised as a deferred tax asset due to the low probability that these losses will be able to be utilised in operating activities.
Statutory basic earnings per share (‘EPS’) was a loss of 4.5 pence (2018: profit of 10.7 pence) due to the Frontier one-off costs relating to the acquisition and integration.
Cash flow from operating activities excluding Client Registration Funds (‘CRF’) was £5.4 million (2018: £5.0 million). Reported cash from operating activities in accordance with IFRS was £5.4 million (2018: £5.6 million). The difference in these two metrics relates to the fact that TSG, particularly in the USA, processes regulatory registration payments on behalf of clients. The alternative performance measures, adjusting for CRF, more accurately reflect the Group’s cash position and cash flow.
The cash outflow in acquiring the shares of Frontier was £12.8 million which represented an average price per share of 27.3 pence. Frontier held cash at the end of August 2019 of £2.8 million and had a revolving credit facility with Clydesdale of £5.0 million which was repaid by Science Group following the statutory merger. During the post-acquisition period, the working capital of Frontier was normalised by paying overdue balances owed to suppliers to address the extended payment terms necessitated by Frontier’s financial position. Partially offsetting this was the reduction in trade receivables and inventory arising from Frontier’s seasonality which experiences peak shipments in the summer months.
Financing and cash
The Group’s term loan with Lloyds Bank plc (‘Lloyds’), secured on the Group’s freehold properties, is a 10 year fixed term loan expiring in 2026. It was increased during the year to £17.5 million on similar terms to those previously in place. Phased interest rate swaps hedge the loan resulting in a 10 year fixed effective interest rate of 3.6%, comprising a margin over 3 month LIBOR, the cost of the loan arrangement fee and the cost of the swap instruments. The term loan has no operating covenants as long as the Group net bank debt is less than £10 million. If this threshold is crossed, two conditions apply: (i) a financial covenant, measured half-yearly on a 12 month rolling basis, such that annual EBITDA must exceed 1.25 times annual debt servicing (capital and interest) and (ii) a security covenant whereby the loan to value (‘LTV’) ratio of the securitised properties must remain below 75%. If either of these conditions are breached, a remedy period of 6 months is provided, during which time the EBITDA or LTV condition can be remedied or the net bank debt can be reduced to less than £10 million. The Group has adopted hedge accounting for the interest rate swap related to the bank loan under IFRS 9, Financial Instruments, and the loss on change in fair value of the interest rate swaps was £408,000 (2018: gain of £66,000) which was recognised directly within equity.
The Group cash position (excluding CRF) at 31 December 2019 was £13.9 million (2018: £21.5 million) and net debt was £2.3 million (2018: net funds of £8.8 million) following the cash outflows for the consideration of Frontier, restructuring costs and the realignment of the Frontier working capital position. CRF of £1.5 million (2018: £1.5 million) were held at the year end. Working capital management during the year continued to be a focus with debtor days of 32 days at 31 December 2019 (2018: 37 days) while combined debtor and WIP days was similar to prior year at negative 7 days (2018: negative 9 days). (WIP is defined as the net of accrued income and payments received on account). Following the acquisition of Frontier, the Group holds inventory which, at 31 December 2019, was £2.1 million (2018: £nil).
At 31 December 2019, the Company had 41,700,440 ordinary shares in issue (2018: 40,040,227) excluding 361,595 shares in treasury (2018: 2,021,808). Of the ordinary shares in issue, 104,400 (2018: nil) shares are held by the EBT and hence the voting rights in the Company are 41,596,040. In this report, all references to measures relative to the number of shares in issue exclude shares held in treasury unless explicitly stated to the contrary.
Employee Benefit Trust
Prior to acquisition, Frontier Smart Technologies Employee Benefit Trust (‘EBT’) held 2.0 million Frontier shares. On completion of the statutory merger, the EBT received £0.5 million in settlement of the shares of which £0.3 million was paid to SG Bidco Limited to settle an outstanding loan. 104,400 shares in Science Group plc were acquired by the EBT (by issuing shares held in treasury) which will be used to satisfy employee share options issued to the Joint Managing Directors of the Frontier business. The voting rights and right to dividends in respect of the ordinary shares held by the EBT are waived.
About Science Group
Science Group is an international science, engineering and technology (“SET”) business providing a range of services to the medical, defence, industrial, food & beverage and consumer sectors, supplemented by a strategic products division where the Group holds leading market positions in associated technology sectors.